Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Boehringer Ingelheim
Biotech
Boehringer drops obesity drug from Gubra partnership
The three other projects in the team-up, including two preclinical assets and another currently in a phase 1 trial, are still ongoing.
Darren Incorvaia
Oct 31, 2024 1:22pm
Notable goes bankrupt, ending plans for Boehringer cancer drug
Oct 15, 2024 8:45am
Boehringer inks $607M Circle pact for preclinical cancer program
Oct 9, 2024 8:36am
Boehringer's phase 3 lung fibrosis trial hits primary endpoint
Sep 16, 2024 8:30am
Boehringer, Bayer advance lung cancer meds toward Enhertu battle
Sep 9, 2024 4:43pm
Boehringer offers up to $1.3B for checkpoint inhibitor biotech
Jul 29, 2024 10:31am
